44. Design Thinking in Biotech w/ Chris Garabedian - CEO @ Xontogeny / Former CEO @ Sarepta
BIOS
00:00
Optimizing Biotech Investments for Success
The chapter emphasizes the significance of having a clear ultimate goal in biotech investments, particularly focusing on achieving successful clinical proof of concept studies in patients to create substantial value in the industry. It discusses the importance of well-designed studies, varied experiments, tailored approaches, and experienced guidance to accelerate drug program development and attract further investments. The conversation also touches on the challenges of talent acquisition, historical shifts in biotech investment trends, the importance of networking, seeking advice, and balancing data analytics with gut instinct in decision-making for future success in the industry.
Transcript
Play full episode
